A clinical formulation indicated for Bladder and Urinary needs. This medication supports the relaxation of the bladder muscle to increase capacity and manage frequent urges to urinate.
A beta-3 agonist intended to manage overactive bladder symptoms and designed to alleviate urinary urgency to support better bladder control.
Mechanism of Action
It relaxes the detrusor muscle in the bladder wall during the filling phase. This increases bladder capacity and reduces the frequency of involuntary contractions.
Route of Administration
Oral
Onset Time
Within 1 week (full effect 8 weeks)
Duration
24 hours
Contraindications
Severe uncontrolled hypertension, Severe liver or kidney disease, Allergy to mirabegron
Severe Adverse Events
Hypertensive crisis, Urinary retention, Severe allergic reaction, Atrial fibrillation
Common Side Effects
Dry mouth, Nausea
Uncommon Side Effects
High blood pressure, Headache, Urinary tract infection, Constipation
Information for Myrbetriq is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
